TRT PHARMA INC.
2Patents
2Active
2Granted
38Portfolio score
Filing activity: Nov 25, 2009 → May 31, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8470889B2 | Hybrid-ionone and curcumin molecules as anticancer agents | Chemistry; Metallurgy | 1 | Active |
| US9139592B2 | Modulators of Nrf2 and uses thereof | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.